These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25617013)

  • 21. Thalidomide: emerging role in cancer medicine.
    Richardson P; Hideshima T; Anderson K
    Annu Rev Med; 2002; 53():629-57. PubMed ID: 11818493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalidomide: an experience in therapeutic outcome and adverse reactions.
    Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
    J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide in the management of epidermolysis bullosa pruriginosa.
    Ozanic Bulic S; Fassihi H; Mellerio JE; McGrath JA; Atherton DJ
    Br J Dermatol; 2005 Jun; 152(6):1332-4. PubMed ID: 15949003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide: an old drug with new clinical applications.
    Laffitte E; Revuz J
    Expert Opin Drug Saf; 2004 Jan; 3(1):47-56. PubMed ID: 14680461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide and its impact in dermatology.
    Stirling DI
    Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The revival of thalidomide: an old drug with new indications].
    Laffitte E
    Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thalidomide once more in the spotlight].
    de Jong-van den Berg LT; Rutgers J; Cornel MC
    Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2509-12. PubMed ID: 10028338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
    Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
    Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide: when everything old is new again.
    Nirenberg A
    Clin J Oncol Nurs; 2001; 5(1):15-8. PubMed ID: 11899395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
    Pałgan K; Pałgan I; Dziedziczko A
    Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful management of refractory pediatric-onset complex aphthosis with lenalidomide.
    Kalampokis I; Rabinovich CE
    J Clin Rheumatol; 2014 Jun; 20(4):221-3. PubMed ID: 24847750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
    Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
    Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of thalidomide in the treatment of cancer.
    Rajkumar SV
    Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide in cancer medicine.
    Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
    Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
    Flowers ME; Martin PJ
    Leuk Lymphoma; 2003 Jul; 44(7):1141-6. PubMed ID: 12916865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.